Answers are grounded in this paper and cite their sources.
Investigates DLK1 as a biomarker predicting poor prognosis in hepatocellular carcinoma patients after surgery, indicating its therapeutic potential.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: